Rationale for the Role of Heparin and Related GAG Antithrombotics in COVID-19 Infection

被引：19

作者：

Magnani, Harry N. ^{[1
]}

机构：

[1] Aspen Pharma, Schoutstr 54, NL-5345 MT Oss, Netherlands

来源：

CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS | 2021年 / 27卷

关键词：

COVID-19; pathophysiology; GAG-antithrombotics; danaparoid sodium; sulodexide; INDUCED THROMBOCYTOPENIA; DERMATAN SULFATE; PLATELET-FACTOR-4; COAGULATION; HEPARANASE; THROMBOMODULIN; ACTIVATION; SULODEXIDE; ANTIBODIES; SUBSTRATE;

D O I：

10.1177/1076029620977702

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The SARS-CoV-2 pandemic has focused attention on prevention, restriction and treatment methods that are acceptable worldwide. This means that they should be simple and inexpensive. This review examines the possible role of glycosaminoglycan (GAG) antithrombotics in the treatment of COVID-19. The pathophysiology of this disease reveals a complex interplay between the hemostatic and immune systems that can be readily disrupted by SARS-CoV-2. Some of the GAG antithrombotics also possess immune-modulatory actions and since they are relatively inexpensive they could play an important role in the management of COVID-19 and its complications.

引用

页数：26

共 184 条

[71] Danaparoid sodium-based anticoagulation therapy for portal vein thrombosis in cirrhosis patients [J].

Hayashi, Takehiro ;

Takatori, Hajime ;

Horii, Rika ;

Nio, Kouki ;

Terashima, Takeshi ;

Iida, Noriho ;

Kitahara, Masaaki ;

Shimakami, Tetsuro ;

Arai, Kuniaki ;

Kitamura, Kazuya ;

Kawaguchi, Kazunori ;

Yamashita, Taro ;

Sakai, Yoshio ;

Yamashita, Tatsuya ;

Mizukoshi, Eishiro ;

Honda, Masao ;

Toyama, Tadashi ;

Okumura, Kenichiro ;

Kozaka, Kazuto ;

Kaneko, Shuichi .

BMC GASTROENTEROLOGY, 2019, 19 (01)

[72] Vascular dermatan sulfate regulates the antithrombotic activity of heparin cofactor II [J].

He, Li ;

Giri, Tusar K. ;

Vicente, Cristina P. ;

Tollefsen, Douglas M. .

BLOOD, 2008, 111 (08) :4118-4125

[73]

Henry BM, 2020, NEW ENGL J MED, V382, P1860, DOI 10.1056/NEJMc2005203

[74] CHARACTERISTICS OF THE CHEMOTACTIC ACTIVITY OF HEPARIN COFACTOR-II PROTEOLYSIS PRODUCTS [J].

HOFFMAN, M ;

PRATT, CW ;

CORBIN, LW ;

CHURCH, FC .

JOURNAL OF LEUKOCYTE BIOLOGY, 1990, 48 (02) :156-162

[75]

Hoppensteadt D., 2008, FASEB, V22, P1118

[76] Re The source of elevated plasma D-dimer levels in COVID-19 infection [J].

Hunt, Beverley J. ;

Levi, Marcel .

BRITISH JOURNAL OF HAEMATOLOGY, 2020, 190 (03) :E133-E134

[77] Mechanisms of glycosaminoglycan activation of the serpins in hemostasis [J].

Huntington, JA .

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2003, 1 (07) :1535-1549

[78] COVID-19 and diabetes: Knowledge in progress [J].

Hussain, Akhtar ;

Bhowmik, Bishwajit ;

do Vale Moreira, Nayla Cristina .

DIABETES RESEARCH AND CLINICAL PRACTICE, 2020, 162

[79] The complement system in COVID-19: friend and foe? [J].

Java, Anuja ;

Apicelli, Anthony J. ;

Liszewski, M. Kathryn ;

Coler-Reilly, Ariella ;

Atkinson, John P. ;

Kim, Alfred H. J. ;

Kulkarni, Hrishikesh S. .

JCI INSIGHT, 2020, 5 (15)

[80] Cytomegalovirus-induced thrombotic microangiopathy after renal transplant successfully treated with eculizumab: case report and review of the literature [J].

Java, Anuja ;

Edwards, Angelina ;

Rossi, Ana ;

Pandey, Richa ;

Gaut, Joseph ;

Delos Santos, Rowena ;

Miller, Brent ;

Klein, Christina ;

Brennan, Daniel .

TRANSPLANT INTERNATIONAL, 2015, 28 (09) :1121-1125

← 3 4 5 6 7 8 9 10 11 12 →